Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v7-EN
Language French English
Date Updated 2022-04-28 2021-05-20
Drug Identification Number 02302861 02302861
Brand name ACT PIOGLITAZONE ACT PIOGLITAZONE
Common or Proper name PIOGLITAZONE 15MG TAB PIOGLITAZONE 15MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PIOGLITAZONE PIOGLITAZONE
Strength(s) 15MG 15MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code A10BG A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-04-20 2021-04-20
Estimated end date 2021-09-30
Actual end date 2022-04-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments